CN105456288B - Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof - Google Patents

Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof Download PDF

Info

Publication number
CN105456288B
CN105456288B CN201510943741.8A CN201510943741A CN105456288B CN 105456288 B CN105456288 B CN 105456288B CN 201510943741 A CN201510943741 A CN 201510943741A CN 105456288 B CN105456288 B CN 105456288B
Authority
CN
China
Prior art keywords
preparation
magnesium
hydrogen
health
mgh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510943741.8A
Other languages
Chinese (zh)
Other versions
CN105456288A (en
Inventor
袁广银
裴佳
丁文江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiaotong University
Original Assignee
Shanghai Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiaotong University filed Critical Shanghai Jiaotong University
Priority to CN201510943741.8A priority Critical patent/CN105456288B/en
Publication of CN105456288A publication Critical patent/CN105456288A/en
Priority to PCT/CN2017/071165 priority patent/WO2017101887A1/en
Application granted granted Critical
Publication of CN105456288B publication Critical patent/CN105456288B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Abstract

The invention discloses a health-care medicinal preparation with magnesium supplement and antioxidation functions and a preparation method thereof2The micro-nano powder is prepared from the auxiliary materials which are common pharmaceutical preparation auxiliary materials. Compared with the existing magnesium-supplementing preparation, the preparation of the invention has the advantages of one-time administration, simultaneous supplement of trace element magnesium and hydrogen element with antioxidation for neutralizing oxygen free radical, convenient storage and administration, high conversion efficiency, good absorption effect, low cost and no toxic or side effect. The preparation can effectively prevent various adverse symptoms caused by magnesium deficiency, and has effects of inducing hydrogen antioxidation, relieving inflammation, strengthening body constitution, delaying aging, and preventing diseases.

Description

Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof
Technical Field
The invention relates to the field of pharmaceutical preparations, in particular to a health-care pharmaceutical preparation with magnesium supplement and antioxidation.
Background
With the improvement of living standard, aging of population and change of life style, health care is increasingly paid attention to people. Some trace elements play a very important role in human health, such as magnesium element, which participates in the synthesis of all energy metabolism proteins in vivo, activates and catalyzes various enzyme systems, regulates the nervous system, ensures the normal contraction of cardiac muscle, enhances the immune function of the organism, protects the bone health and the like. The magnesium deficiency of human body may cause cardiovascular and cerebrovascular diseases, hypertension, diabetes, osteoporosis, migraine, anxiety, depression and other symptoms, and seriously endanger human health. Therefore, the proper amount of magnesium supplement has important significance on human health. According to the Chinese society for nutrition, about 350 mg of magnesium is required for adult men, about 300 mg for adult women, and about 450 mg for pregnant and lactating women. However, in many cases, it is difficult to sufficiently compensate for the deficiency only by diet, and a magnesium nutritional supplement is required. The magnesium health care nutriment which is most common in the market at present is magnesium salt such as magnesium oxide, magnesium gluconate, magnesium citrate, magnesium salicylate, magnesium hydroxide, magnesium chloride, magnesium sulfate and the like. There are major problems including the general lack of magnesium content; the conversion and absorption efficiency is not low (50-70%); can cause gastrointestinal discomfort and diarrhea, and can also cause side effects of chest tension, bloody stool, mouth, face and tongue swelling, abdominal cramp and the like in severe cases. However, the magnesium salt injection may cause problems of pain at the injection site, vertigo, muscle paralysis, etc. Therefore, there is a need to develop a new magnesium source-supplementing preparation which is safe, has no toxic and side effects, and has higher magnesium content and absorption and conversion efficiency.
Studies have shown that human health is also closely related to oxygen free radicals in the body. The surplus of oxygen radicals may cause cell damage or aging necrosis, eventually leading to diseases and aging of the body. Hydrogen is a colorless, tasteless, odorless and nontoxic gas, and a large number of researches show that the hydrogen has selective oxidation resistance, selectively neutralizes hydroxyl radicals and nitrite anions, and the hydroxyl radicals and the nitrite anions are the most important media of oxidative damage, so that an endogenous specific clearance path is not found in vivo at present. The hydrogen ions can be reduced into water after being combined with active oxygen and discharged out of the body, and the medicament is safe and has no toxic or side effect. And hydrogen has strong penetrability and is easy to enter any part of cells such as cell nucleus, mitochondria and the like. These establish the important features of hydrogen available for the treatment of disease. Hydrogen has protective effect on various nervous system injuries, has wide effect on cardiovascular and digestive system injury and diseases, and has therapeutic effect on human diseases such as diabetes, tumor radiotherapy, systemic lupus erythematosus skin injury, rheumatoid arthritis, etc. Therefore, the proper amount of supplemented hydrogen has certain benefits for human bodies. In recent years, hydrogen ion-rich plain water (hydrogenic water) has begun to receive wide attention in the international market. However, hydrogen rich water is limited by the low solubility of hydrogen gas, and generally contains hydrogen only about 0.1 to 1ppm, and up to about 5 ppm. The low hydrogen concentration and poor stability are the biggest problems restricting the effect of the hydrogen supplement health care product at present.
In addition, a preparation or a health care nutrition product capable of simultaneously supplementing magnesium and hydrogen is not seen in China, only Dr. water element water hydrogen-rich water rods introduced in Japan have metal magnesium as an effective component, but the problems exist that 1) magnesium hydroxide is generated when meeting water and is insoluble in water, so that the magnesium cannot be effectively utilized, and the content of magnesium entering a human body is too low; 2) the hydrogen generated immediately after meeting water is easy to escape, is unstable, needs to be taken immediately, is inconvenient to store and place, and has limited concentration of hydrogen dissolved in water; 3) the metal magnesium particles are easily oxidized into insoluble matters to prevent further reaction with water, so that the effect is obviously reduced along with the increase of the use times. The above problems are also encountered in the method and apparatus for producing hydrogen-rich water of patent CN1840497A, and in the method and apparatus for producing hydrogen-rich water of patent CN201785234U, since the active ingredients are magnesium metal. However, the patent CN102557227B "a calcium-magnesium hydrogen-rich water additive and its preparation method" is similar to the principle of the above hydrogen-rich water rod, and the hydrogen production agent is magnesium simple substance or calcium-magnesium alloy, but a pH regulator is additionally added to improve the dissolution of magnesium, but the above problem 2) still remains unsolved.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a health-care medicinal preparation with magnesium supplement and antioxidation, which is characterized in that magnesium hydride MgH is used2The micro-nano powder particles are main active ingredients (magnesium and hydrogen sources) of the preparation, and after the micro-nano powder particles are taken into a human body, the micro-nano powder particles directly convert into magnesium ions in the body through the reaction with water in the body and simultaneously generate hydrogen, thereby providing a new way for the human body to absorb magnesium elements and absorb hydrogen. The preparation can be taken for a long time, can effectively prevent symptoms caused by magnesium deficiency, and is beneficial to delaying aging and preventing diseases.
The purpose of the invention is realized by the following technical scheme:
the invention provides a health-care medicinal preparation with magnesium supplement and antioxidation functions, which comprises a main effective component magnesium agent and auxiliary materials, wherein the magnesium agent is MgH2The micro-nano powder is prepared from the auxiliary materials which are common pharmaceutical preparation auxiliary materials.
Preferably, the MgH2The size of the micro-nano powder is 100nm-100 mu m.
MgH2The magnesium powder exists in the form of micro-nano powder, the oxidation activity of the single magnesium powder of 100nm-100 mu m is very high, and oxidation exothermic reaction is easy to occur in the air, even dangerous accidents such as explosion are caused. And MgH is formed by combining Mg powder and hydrogen2The micro-nano powder of the compound becomes very stable and safe. Simultaneously MgH2And is a stable and reliable source of hydrogen. Once MgH2After the micro-nano powder enters the human body through the gastrointestinal tract, MgH is subjected to the following chemical reaction2+2H2O→Mg2++2OH-+2H2I.e. react to form Mg absorbable by the human body2+And hydrogen, thereby producing a health-care effect beneficial to the human body.
The size range of 100nm-100 mu m is selected, the preparation process in the size range is most economical, and the size range is convenient to be absorbed by human bodies. Particles below 100nm, the preparation cost increases dramatically; the size of more than 100 mu m is not beneficial to the absorption of human body.
Preferably, the weight content of the magnesium element in the medicine preparation is 40-400 mg/dose.
Preferably, the hydrogen content produced by the pharmaceutical preparation when taken is 72-720m L per dose.
Preferably, the pharmaceutical formulation is in the form of a tablet, pill or capsule.
The invention also provides a preparation method of the health care medicine preparation for simultaneously supplementing magnesium and hydrogen, and the preparation method comprises the following steps: adding a certain amount of MgH2The micro-nano powder is evenly mixed with a proper amount of common pharmaceutical excipients, and is prepared after weighing, material distribution, compaction, sterilization treatment and packaging processing.
Compared with the prior art, the invention has the following beneficial effects:
1. the magnesium and hydrogen supplement preparation can simultaneously supplement trace element magnesium and hydrogen for neutralizing oxygen free radical which are necessary for human bodies after being taken once.
2. The prior art reaction equation is as follows:
Mg+2H2O→Mg(OH)2+ H2
the reaction equation of the present invention is improved as follows:
MgH2+2H2O→Mg2++2OH-+2H2
MgH as shown in the reaction formula2The hydrogen production efficiency is 2 times higher than that of magnesium metal. And supplement magnesium source MgH2Is directly converted into soluble magnesium salt in vivo after being taken, and is not insoluble magnesium hydroxide in the prior art. Thus, the conversion and absorption efficiency can be improved to a large extent.
3. Different from the limit of low hydrogen solubility of hydrogen-rich water/aqueous vegetable water, the preparation replenishes hydrogen generated after entering human bodies, so that the concentration of the replenished hydrogen is greatly improved, and the antioxidant health care and treatment effects of the hydrogen can be better exerted.
4. The preparation reaction metabolite has no toxic or side effect or adverse reaction, is safe and reliable, is convenient to store and take, and can greatly improve the use convenience and the user experience.
5. The preparation contains magnesium hydride MgH as main effective component2The production cost of the micro-nano powder is low, and the micro-nano powder is convenient for large-scale production.
Detailed Description
The present invention will be described in detail with reference to specific examples. The following examples will assist those skilled in the art in further understanding the invention, but are not intended to limit the invention in any way. It should be noted that variations and modifications can be made by persons skilled in the art without departing from the spirit of the invention. All falling within the scope of the present invention.
Example 1
Preparing the magnesium hydride into micro powder with the dimension of 100-200 nm, taking 250g of the powder, adding 500g of pregelatinized starch and 250g of microcrystalline cellulose, uniformly mixing, and pressing into 1000 tablets to obtain the tablet. Each tablet has a weight of 1g, and can be swallowed by adult in 2 tablets per day and children in 1-2 times per day, once per day. After the medicine is continuously taken for 1-2 weeks, the leg muscle soreness caused by mountain climbing or long-distance running can be effectively relieved and eliminated due to effective supplement of magnesium.
Example 2
Preparing the magnesium hydride into 600-mesh micropowder of 400 meshes, taking 150g of the micropowder, adding 150g of mannitol, 120g of superfine silica gel powder and 80g of alginic acid, grinding, sieving, mixing uniformly and then filling into capsules to obtain 1000 granules. Each capsule is 0.5g, and is swallowed by adult 2-3 capsules per day in 1-3 times, and children 1-2 capsules per day in 1-2 times. Animal experiments prove that the white mice with pneumonia continuously take the medicinal powder in the capsules for 2 weeks, 1 granule of the medicinal powder is mixed into mouse food every day for taking, the inflammation of the pneumonia of the white mice enters body fluid due to hydrogen to play an effective anti-inflammatory role, the pneumonia symptoms are effectively treated and relieved after 2 weeks, and the pneumonia is completely cured after 3 weeks of taking.
Example 3
Preparing magnesium hydride into 500 nm-1 micron micropowder, collecting powder 200g, adding lactose 150g, dextrin 100g, and CMC 50g, mixing, and making into pill to obtain 1000 granules. Each granule has a weight of 0.5g, and is administered 1-2 times daily for adults and 1-2 times daily for children. Animal experiments prove that the guinea pig suffering from hepatitis continuously takes the pills for 1 month, 1 pill of medicinal powder is mixed into mouse food for administration every day, the inflammation of the hepatitis of the guinea pig enters body fluid due to hydrogen to play an effective anti-inflammatory and anti-oxidation role, the hepatitis symptom is effectively treated and relieved in ten days, and the hepatitis is completely cured after 4 weeks of administration.
Example 4
Preparing magnesium hydride into 1-10 micron micropowder, collecting powder 350g, adding mannitol 300g and microcrystalline cellulose 150g, mixing, making into tablet, and coating sugar coat on the surface to obtain 1000 tablets. Each tablet weighs 0.8g, and is swallowed by 1 tablet per day for adults. After being continuously taken for 2 weeks, the insomnia phenomenon caused by the nerve dysfunction can be effectively relieved and disappeared due to the effective supplement of magnesium.
Example 5
Preparing magnesium hydride into 1000-fold 1500-mesh micro powder, taking 40g of powder as a trace element additive, adding 100 commercially available folic acid tablets, grinding, uniformly mixing, and pressing into tablets again to obtain 100 tablets. The pregnant woman can take 1 tablet daily. Can help pregnant women supplement folic acid and essential element magnesium. After being continuously taken for 1-2 months, gastrointestinal dysfunction symptoms such as abdominal fullness, borborborygmus, sigh, anorexia, vomit, diarrhea or constipation caused by nerve dysfunction of some middle-aged and elderly people can be effectively relieved and eliminated due to the regular supplement of magnesium ions and the antioxidation of hydrogen.
Example 6
Preparing magnesium hydride into 1000-plus 1500-mesh micro powder, taking 30g of powder as a trace element additive, adding 100 commercially available calcium supplement tablets, grinding, uniformly mixing, and pressing into tablets again to obtain 100 tablets. The tablet is taken by adult 1 tablet per day. Meanwhile, magnesium supplement can help osteoporosis patients to enhance the absorption and utilization of calcium. After the medicine is continuously taken for 1-3 months, the symptoms of lassitude, hypodynamia, cramp, soreness of waist and back pain, easy allergy, easy cold and the like of adult men caused by calcium deficiency and magnesium deficiency can be effectively relieved and cured due to the effective supplement of magnesium and calcium and the anti-inflammatory and anti-oxidation effects of hydrogen.
The specific embodiments of the present invention have been described above in detail. It should be understood that numerous modifications and variations could be devised by those skilled in the art in light of the present teachings without departing from the inventive concepts. Therefore, the technical solutions available to those skilled in the art through logic analysis, reasoning and limited experiments based on the prior art according to the concept of the present invention should be within the scope of protection defined by the claims.

Claims (3)

1. The application of a medicinal preparation in preparing a health-care medicinal preparation with the functions of supplementing magnesium and resisting oxidation is characterized in that the medicinal preparation comprises a main effective component magnesium agent and auxiliary materials, wherein the magnesium agent is MgH2Micro-nano powder, wherein the auxiliary material is a common pharmaceutical preparation auxiliary material; the MgH2The size of the micro-nano powder is 100nm-600 meshes; the weight content of the magnesium element in the medicine preparation is 40-400 mg/dose; the MgH2After the micro-nano powder enters a human body through the gastrointestinal tract, MgH is chemically reacted2+2H2O→Mg2++2OH-+2H2I.e. react to form Mg absorbable by the human body2+And hydrogen, wherein the content of hydrogen generated by the medicine preparation when the medicine preparation is taken is 72-720m L per dose.
2. Use of a pharmaceutical preparation according to claim 1 for the preparation of a health care pharmaceutical preparation for magnesium supplementation with an antioxidant effect, wherein the pharmaceutical preparation is in the form of a tablet, a pill or a capsule.
3. The use of the pharmaceutical preparation according to claim 1 for the preparation of a health-care pharmaceutical preparation for magnesium supplementation and antioxidation, wherein the preparation method comprises the following steps: MgH is added2Mixing the micro-nano powder with common medicinal adjuvants, weighing, separating, compacting, sterilizing, and packaging.
CN201510943741.8A 2015-12-15 2015-12-15 Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof Active CN105456288B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201510943741.8A CN105456288B (en) 2015-12-15 2015-12-15 Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof
PCT/CN2017/071165 WO2017101887A1 (en) 2015-12-15 2017-01-13 Healthcare pharmaceutical preparation having magnesium supplementation and anti-oxidation effects, and preparation method for healthcare pharmaceutical preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510943741.8A CN105456288B (en) 2015-12-15 2015-12-15 Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof

Publications (2)

Publication Number Publication Date
CN105456288A CN105456288A (en) 2016-04-06
CN105456288B true CN105456288B (en) 2020-07-14

Family

ID=55594753

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510943741.8A Active CN105456288B (en) 2015-12-15 2015-12-15 Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof

Country Status (2)

Country Link
CN (1) CN105456288B (en)
WO (1) WO2017101887A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105456288B (en) * 2015-12-15 2020-07-14 上海交通大学 Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof
CN108165395A (en) * 2017-12-29 2018-06-15 上海交通大学 The preparation method of hydrogen foam beer
CN108041399A (en) * 2017-12-29 2018-05-18 上海交通大学 The preparation method of hydrogen foam soft drink
CN110155942B (en) * 2019-05-17 2023-04-11 上海镁源动力科技有限公司 Slow-release hydrogen preparation based on magnesium hydride and preparation method thereof
CN113616671B (en) * 2020-05-09 2022-06-28 上海交通大学 Micro-nano MgH2Application of compound particles in preparation of medicines for inhibiting leishmania infection and treating leishmania
CN114948989A (en) * 2021-02-19 2022-08-30 中国人民解放军海军军医大学 Application of magnesium hydride in preparing medicine for preventing and treating kidney crystal lithiasis
CN114948990A (en) * 2021-02-22 2022-08-30 上海市肺科医院 Application of magnesium hydride in preparing medicine for preventing and treating acute respiratory distress syndrome
CN114191409A (en) * 2021-10-15 2022-03-18 张树刚 Hydrogen capsule based on health care, anticancer, antioxidation and toxin expelling
CN114452299A (en) * 2022-02-10 2022-05-10 中国人民解放军火箭军特色医学中心 Application of MgH2 in preparation of medicine for treating male fertility damage caused by ionizing radiation
CN116458589A (en) * 2023-04-21 2023-07-21 艾敕迩(东莞)氢能科技有限公司 Raw material proportioning process for preparing hydrogen tablets

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101951929A (en) * 2007-12-28 2011-01-19 水株式会社 External preparation for preventive or therapeutic use
CN102557227A (en) * 2012-03-12 2012-07-11 彭振业 Additive of calcium magnesium hydrogen-rich water and preparation method of additive
CN103415294A (en) * 2011-02-17 2013-11-27 生物焦炭技术研究株式会社 Hydrogen-emitting composition
CN104306398A (en) * 2014-09-18 2015-01-28 宋忠慎 Low cost preparation method for negative hydrogen ion antioxidant and zinc-boron supplement

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1225920A (en) * 1998-02-10 1999-08-18 张经坤 Method for preparing amino acid-magnesium chelate and use thereof
CN100554142C (en) * 2006-08-04 2009-10-28 北京大学 Magnesium hydride nano particle and its production and application
CN113143901A (en) * 2007-03-22 2021-07-23 纽罗森特里亚股份有限公司 Magnesium composition and use thereof
CN102783691A (en) * 2012-08-20 2012-11-21 李志林 Calcium-magnesium hydrogen producing agent
JP2014064551A (en) * 2012-09-26 2014-04-17 Techno Bank:Kk Supplement candy
DE102012217387A1 (en) * 2012-09-26 2014-04-17 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Therapeutic use of hydrogen molecules
CN103626669A (en) * 2013-12-13 2014-03-12 四川生科力科技有限公司 Preparation method of magnesium glycinate chelate
CN105456288B (en) * 2015-12-15 2020-07-14 上海交通大学 Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101951929A (en) * 2007-12-28 2011-01-19 水株式会社 External preparation for preventive or therapeutic use
CN103415294A (en) * 2011-02-17 2013-11-27 生物焦炭技术研究株式会社 Hydrogen-emitting composition
CN102557227A (en) * 2012-03-12 2012-07-11 彭振业 Additive of calcium magnesium hydrogen-rich water and preparation method of additive
CN104306398A (en) * 2014-09-18 2015-01-28 宋忠慎 Low cost preparation method for negative hydrogen ion antioxidant and zinc-boron supplement

Also Published As

Publication number Publication date
WO2017101887A1 (en) 2017-06-22
CN105456288A (en) 2016-04-06

Similar Documents

Publication Publication Date Title
CN105456288B (en) Health-care medicinal preparation for supplementing magnesium and resisting oxidation and preparation method thereof
CN103054044B (en) Sleep-improving health food composition
US20170209486A1 (en) Health-care preparation simultaneously with magnesium supplement and antioxidant functions and preparation method thereof
CN102626225B (en) Health food having functions of bone density increasing and joint protecting, and preparation method thereof
US20190166885A1 (en) Composition for producing hydrogen rich water and other products
CN104257748A (en) Health product formula
CN101053621B (en) Traditional Chinese medicinal composition for treating obesity and its preparation method
CN106509887A (en) Fatigue preventing health-care composition and a preparation method thereof
CN102228595A (en) Chinese prescription energy pure Chinese medicine extract with anti-aging function
CN105433382B (en) A kind of maca composition and its preparation method and application
CN108815218A (en) Medical composition and its use
CN103005435B (en) Anti-fatigue composition capable of improving speed endurance and preparation containing anti-fatigue composition
CN108813610A (en) A kind of saussurea involucrata composition and its application for improving immunity
CN107373274A (en) Vitamin c effervescent tablet and preparation method thereof
CN107898924B (en) Chinese herbal medicine for treating osteoporosis and preparation method of gel patch thereof
CN104585763A (en) Liver-protecting and liver-nourishing functional food and preparation method thereof
CN106912920A (en) A kind of composition containing mulberry-leaf extract and application thereof
CN102784230B (en) Pharmaceutical composition preparation for treating nutritional anemia
CN104256582B (en) A kind of health caring product prescription alleviating the various symptom of Women’s climacteric
CN103223080A (en) Traditional Chinese medicinal composition for tranquilizing mind by nourishing the heart and preparation method thereof
Newnham How boron is being used in medical practice
CN106174563A (en) A kind of health product improving immunity of organisms
CN102886042A (en) Combination containing complex nucleoside, glutathione and yeast extract and application of combination in aspects of alleviating hangover and protecting liver
CN105853826A (en) Tumor preventing and treating medicine and application of medicine
CN117018125B (en) Anti-fatigue pharmaceutical composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant